HOTH
Price
$1.13
Change
-$0.04 (-3.42%)
Updated
Jun 27 closing price
Capitalization
15.06M
OGEN
Price
$4.05
Change
+$0.56 (+16.05%)
Updated
Jun 27 closing price
Capitalization
2.9M
Interact to see
Advertisement

HOTH vs OGEN

Header iconHOTH vs OGEN Comparison
Open Charts HOTH vs OGENBanner chart's image
Hoth Therapeutics
Price$1.13
Change-$0.04 (-3.42%)
Volume$432.11K
Capitalization15.06M
Oragenics
Price$4.05
Change+$0.56 (+16.05%)
Volume$309.88K
Capitalization2.9M
HOTH vs OGEN Comparison Chart in %
Loading...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOTH vs. OGEN commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOTH is a Hold and OGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (HOTH: $1.14 vs. OGEN: $4.05)
Brand notoriety: HOTH and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOTH: 30% vs. OGEN: 99%
Market capitalization -- HOTH: $15.06M vs. OGEN: $2.9M
HOTH [@Biotechnology] is valued at $15.06M. OGEN’s [@Biotechnology] market capitalization is $2.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOTH’s FA Score shows that 1 FA rating(s) are green whileOGEN’s FA Score has 0 green FA rating(s).

  • HOTH’s FA Score: 1 green, 4 red.
  • OGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, HOTH is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOTH’s TA Score shows that 6 TA indicator(s) are bullish while OGEN’s TA Score has 5 bullish TA indicator(s).

  • HOTH’s TA Score: 6 bullish, 5 bearish.
  • OGEN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than HOTH.

Price Growth

HOTH (@Biotechnology) experienced а -5.79% price change this week, while OGEN (@Biotechnology) price change was +10.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

HOTH is expected to report earnings on May 12, 2025.

OGEN is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOTH($15.1M) has a higher market cap than OGEN($2.9M). HOTH YTD gains are higher at: 52.386 vs. OGEN (-63.444). HOTH has higher annual earnings (EBITDA): -9.53M vs. OGEN (-10.11M). HOTH has more cash in the bank: 11.3M vs. OGEN (3.42M). HOTH has less debt than OGEN: HOTH (28.9K) vs OGEN (2.55M). HOTH (0) and OGEN (0) have equivalent revenues.
HOTHOGENHOTH / OGEN
Capitalization15.1M2.9M521%
EBITDA-9.53M-10.11M94%
Gain YTD52.386-63.444-83%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.3M3.42M330%
Total Debt28.9K2.55M1%
FUNDAMENTALS RATINGS
HOTH vs OGEN: Fundamental Ratings
HOTH
OGEN
OUTLOOK RATING
1..100
1686
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3897
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
295

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOTH's Valuation (22) in the Pharmaceuticals Major industry is somewhat better than the same rating for OGEN (78) in the Biotechnology industry. This means that HOTH’s stock grew somewhat faster than OGEN’s over the last 12 months.

HOTH's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as OGEN (100) in the Biotechnology industry. This means that HOTH’s stock grew similarly to OGEN’s over the last 12 months.

HOTH's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as OGEN (100) in the Biotechnology industry. This means that HOTH’s stock grew similarly to OGEN’s over the last 12 months.

HOTH's Price Growth Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for OGEN (97) in the Biotechnology industry. This means that HOTH’s stock grew somewhat faster than OGEN’s over the last 12 months.

HOTH's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as OGEN (100) in the Biotechnology industry. This means that HOTH’s stock grew similarly to OGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOTHOGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NIXX1.800.02
+1.12%
Nixxy, Inc.
CPF27.800.20
+0.72%
Central Pacific Financial Corp
SILC15.680.09
+0.55%
Silicom Ltd
DAY55.140.02
+0.04%
Dayforce
CNK30.10-0.33
-1.08%
Cinemark Holdings

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with TIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
-2.56%
TIL - HOTH
34%
Loosely correlated
+3.61%
PPTDF - HOTH
32%
Poorly correlated
N/A
AIM - HOTH
30%
Poorly correlated
-7.04%
OGEN - HOTH
28%
Poorly correlated
+16.05%
INO - HOTH
27%
Poorly correlated
-6.22%
More

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
+16.05%
ATHA - OGEN
44%
Loosely correlated
-2.64%
REVB - OGEN
36%
Loosely correlated
-7.10%
SRPT - OGEN
30%
Poorly correlated
-0.81%
LYRA - OGEN
28%
Poorly correlated
-30.83%
CHRS - OGEN
27%
Poorly correlated
+1.01%
More